Abstract

No AccessJournal of UrologyAdult Urology23 Mar 2023Editorial CommentThis article comments on the following:The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients With Metastatic Castration-sensitive Prostate Cancer Zachary Klaassen, Salil Ghamande, and Christopher J.D. Wallis Zachary KlaassenZachary Klaassen Division of Urology, Department of Surgery, Medical College of Georgia–Augusta University, Augusta, Georgia Georgia Cancer Center, Augusta, Georgia More articles by this author , Salil GhamandeSalil Ghamande Medical College of Georgia, Augusta, Georgia More articles by this author , and Christopher J.D. WallisChristopher J.D. Wallis Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada Division of Urology, Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada Division of Urology, Department of Surgery, University Health Network, Toronto, Ontario, Canada More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003370.03AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, Publish Ahead of Print, pp. – REFERENCES 1. . Real-world utilization of androgen deprivation therapy-intensification among older Canadian men with de novo metastatic prostate cancer. JNCI Cancer Spectr. 2021; 5(6):pkab082. Crossref, Medline, Google Scholar 2. . Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration. Cancer Med. 2021; 10(23):8570-8580. Crossref, Medline, Google Scholar 3. . Treatment pattern and outcomes with systemic therapy in men with metastatic prostate cancer in the real-world patients in the United States. Cancers (Basel). 2021; 13(19):4951. Crossref, Medline, Google Scholar 4. . The role of physician specialty in the underutilization of standard-of-care treatment intensification in patients with metastatic castration-sensitive prostate cancer. J Urol. 2023; 209(6):000-000. Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology15 Feb 2023The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients With Metastatic Castration-sensitive Prostate Cancer Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Zachary Klaassen Division of Urology, Department of Surgery, Medical College of Georgia–Augusta University, Augusta, Georgia Georgia Cancer Center, Augusta, Georgia More articles by this author Salil Ghamande Medical College of Georgia, Augusta, Georgia More articles by this author Christopher J.D. Wallis Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada Division of Urology, Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada Division of Urology, Department of Surgery, University Health Network, Toronto, Ontario, Canada More articles by this author Expand All Advertisement PDF downloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call